Letters, Testimony & Filings Public Citizen Post-hearing Comments re Section 301 Investigation on Germany’s Drug Pricing Policies September 29, 2026
Letters, Testimony & Filings Testimony Before the Food and Drug Administration’s Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee September 23, 2026
Letters, Testimony & Filings Testimony to the Food and Drug Administration’s Public Hearing on Considerations for Potential Future Therapeutic Use of Psychedelic Drugs September 22, 2026
Press Releases Trump’s Drug Pricing Deals Favor Big Pharma Over Patients, Public Citizen FOIA Finds September 19, 2026
Reports Public Citizen FOIA Reveals That Pharma, Not Patients Are Favored In Trump’s Drug Pricing Deals September 19, 2026